CoronaryAtlas logo
CoronaryAtlas
Nuclear factor erythroid 2-related factor 2
Pathway / Endothelial activation & erosion

Nuclear factor erythroid 2-related factor 2

NFE2L2protein

Nrf2 activates endothelial protective antioxidant responses and suppresses dysfunction-driven cap erosion.

Pathway placement
Cascade stepEndothelial activation & erosion
Confidencemedium
RationaleActivates antioxidant pathways protecting endothelial integrity; mediates endothelial detachment resistance.
Also acts inLipid entry/oxidation, Vascular inflammation, Myocardial injury
Druggability
DruggableYes
Known drugs / candidates2
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000116044

Type I vs Type II discrimination

ScoresType-II-associated
R — rupture / Type-I
—
C — confounder / Type-II
67
A — assay feasibility
72
E — evidence strength
46
T1DI (composite)
8
Specificity differential (R−C)-52
Confounder panel (Type-II drivers)
1sepsis / systemic inflammationmag 3
2anemia / acute blood lossmag 2
3hypovolemia / dehydrationmag 2
4tachyarrhythmiamag 2
5hypoxemia / respiratory failuremag 2
6hypertensive emergencyn/a
7high-demand / peri-operative stressmag 1
Coverage: 6/7 confounders with evidence
Tier: deep-scored (abstract-extracted) · 18 supporting references. See the discrimination table for all markers.

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)

Literature evidence(4)